IVSBF (IVSBF) Stock Price & Analysis
IVSBF (IVSBF) rose 1.33% to USD 41.06 as of July 25, 2026 at 03:51 UTC, according to Nexqual real-time market data.
IVSBF last closed at USD 40.52; the session ranged USD 40.5–40.5 on volume of 350 shares. Market capitalization is $125.79B, with a 52-week range of USD 28.2–42.36 (PNK). Source: Nexqual, July 25, 2026 at 03:51 UTC.
Key Statistics (as of July 25, 2026 at 03:51 UTC)
| Price | USD 41.06 |
|---|---|
| Change | ▲ 1.33% (up) |
| Previous Close | USD 40.52 |
| Open | USD 40.5 |
| Day Range | USD 40.5 – 40.5 |
| 52-Week Range | USD 28.2 – 42.36 |
| Volume | 350 shares |
| Market Cap | $125.79B |
| Exchange | PNK |
Technical Analysis (IVSBF)
Nexqual's technical model rates IVSBF "BUY" based on 5 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 03:51 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 54.49 (neutral) |
| vs SMA50 | Above (USD 40.48) |
| MACD | 0.09 (positive) |
Analyst Ratings (IVSBF)
Wall Street analysts rate IVSBF "None", per Nexqual as of July 25, 2026 at 03:51 UTC.
| Consensus Rating | None |
|---|
Earnings (IVSBF)
Source: Nexqual, July 25, 2026 at 03:51 UTC.
Financials & Fundamentals (IVSBF)
| Revenue Growth (YoY) | +117.00% |
|---|---|
| Gross Margin | +89.44% |
| Operating Margin | +0.00% |
| Profit Margin | +80.07% |
| ROE | +27.25% |
| Debt / Equity | 11.59 |
| Current Ratio | 2.24 |
| Free Cash Flow | $166.01B |
Source: Nexqual, July 25, 2026 at 03:51 UTC.
Financial Health Score (IVSBF)
Nexqual rates IVSBF's overall financial health "Solid" across five dimensions, as of July 25, 2026 at 03:51 UTC.
| Growth | Critical — Revenue -14% YoY (annual), sharp decline |
|---|---|
| Profitability | Strong — Gross margin 89%, operating 0% |
| Balance Sheet | Strong — Debt/Equity 0.1x |
| Cash Flow | Strong — FCF $166.0B, 256% margin |
| Efficiency | Strong — ROE 27%, ROA 15.1% |
Ownership (IVSBF)
| Insider Ownership | +0.25% |
|---|---|
| Institutional Ownership | +46.35% |
| Shares Outstanding | 1.82B |
| Float | 2.44B |
Source: Nexqual, July 25, 2026 at 03:51 UTC.
Leadership (IVSBF)
IVSBF is led by Christian Cederholm (age 47), President, CEO, Director & Member of Management Board, per Nexqual as of July 25, 2026 at 03:51 UTC.
| President, CEO, Director & Member of Management Board | Christian Cederholm (age 47) |
|---|---|
| Chief Financial Officer | Jenny Ashman Haquinius (age 39) |
Major Backers & Investors (IVSBF)
Notable institutional backers of IVSBF include Fidelity, First Eagle Funds-First Eagle Global Fund, according to Nexqual as of July 25, 2026 at 03:51 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Fidelity | 1.53% |
| First Eagle Funds-First Eagle Global Fund | 0.94% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 2.37% |
| BlackRock | 1.05% |
Source: Nexqual, July 25, 2026 at 03:51 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IVSXF | Investors AB | USD 40.03 | ▼ 0.25% |
| AXAHF | AXA | USD 50.63 | ▼ 1.4% |
| ZFSVF | Zurich Insurance Group Ltd | USD 770 | ▲ 1.82% |
| TGOPF | 3i Group | USD 36.87 | ▲ 8.79% |
| SHECF | Shin-Etsu Chemical Co., Ltd. | USD 36.85 | ▼ 11.93% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:51 UTC. This page is informational and not investment advice.